Cybin Inc. has been granted U.S. patent number 12,291,499 by the United States Patent and Trademark Office, bolstering its intellectual property portfolio, which now includes over 80 granted patents and more than 230 active applications. CEO Doug Drysdale underscored the significance of strong patent protections in supporting drug innovation and reaffirmed the company’s dedication to […]
The Supreme Court has declined to admit a writ petition filed by the All India Patent Officers’ Welfare Association (AIPOWA), which sought a court-monitored investigation and a probe by the Central Bureau of Investigation (CBI) into alleged unauthorized access and data leakage involving sensitive patent and trademark information. A bench comprising Chief Justice of India
Flux Power Holdings, Inc. (NASDAQ: FLUX), a pioneering developer of advanced lithium-ion energy storage solutions, today announced that it has been granted a patent for its innovative Intelligent Battery Cycle Life Maximization Algorithm. This proprietary AI-driven technology is designed to optimize the performance and longevity of its battery systems by leveraging machine learning to adapt
In a precedential decision issued by the U.S. Court of Appeals for the Federal Circuit in February 2025, the court affirmed a district court ruling that the term “payment handler” in a patent claim was a “nonce” term—a placeholder for functional language. This ruling invoked 35 U.S.C. § 112, sixth paragraph, governing means-plus-function claiming, leading
In a significant breakthrough for maternal healthcare, Akums Drugs & Pharmaceuticals has been granted a patent for its extended-release combination formulation of Doxylamine and Pyridoxine, developed to manage nausea and vomiting in pregnancy (NVP). The formulation, which utilizes Akums’ proprietary “tablet-in-tablet” technology, has recently received approval from the Drug Controller General of India (DCGI). Addressing
In a significant ruling delivered in February 2025, the Delhi High Court reinforced the enforcement of Standard Essential Patents (SEPs) in India, delivering a victory to Philips Koninklijke Philips N.V. (Philips) in its long-standing legal battle against three Indian digital versatile disc (DVD) manufacturers. The case, titled Koninklijke Philips Electronics N.V. v Maj (Retd) Sukesh
In a significant ruling that underscores the importance of transparency, reasoned decision-making, and procedural fairness in patent examination, the Calcutta High Court has set aside a refusal order issued by the Patent Office in the case of Takeda Pharmaceutical Co. Ltd. v. Controller of Patents and Designs & Ors. The Court found that the Patent
Starting May 13, 2025, patent applicants will experience a significant change in the timeline for filing continuation and divisional applications with the U.S. Patent and Trademark Office (USPTO). Under the new rule, the window between paying the issue fee and a patent officially issuing will shrink dramatically—from about three weeks to just one week. For
“The needle has moved,” declares Anil Matai, Director General of the Organization of Pharmaceutical Producers of India (OPPI), in a recent podcast interview with Scrip. The statement refers to the substantial changes in India’s intellectual property rights (IPR) regime, which witnessed some critical amendments in the past year. As the representative body for foreign pharmaceutical
In a significant step forward for drought preparedness and management, the Indian Patent Office has granted a patent for an advanced system that utilizes AI, Internet of Things (IoT), and geospatial technologies to monitor and assess drought conditions in real time. Designed to address the pressing need for accurate and timely drought data—particularly in vulnerable
